Feel the urgency to accelerate patient access to care? Eager to scale up the capabilities of your team in a volatile and unpredictable ecosystem ? Curious to learn more ? We invite you to connect at : contact@curaaccessum.com

Provide strategic leadership & direction on access potential for Early assets and New product - BD&L- Cell and Gene therapy for orphan and ultra orphan indications

- Orphan drugs : relaunch Duodopa in APD - secured positive HTAs opinions and implemented managed entry agreement - Supported the launch of DUOPA in the US-HCV/HEP C- MAVIRET- pre launch Value Access communication and price strategy- Affiliates and regions engagement -Product launch with fast access aligned with the plan- Drove access for Botox indications - leading KAM strategy and execution - establish agile framework for private and public partnership that triggered extra fund by… Show more - Orphan drugs : relaunch Duodopa in APD - secured positive HTAs opinions and implemented managed entry agreement - Supported the launch of DUOPA in the US-HCV/HEP C- MAVIRET- pre launch Value Access communication and price strategy- Affiliates and regions engagement -Product launch with fast access aligned with the plan- Drove access for Botox indications - leading KAM strategy and execution - establish agile framework for private and public partnership that triggered extra fund by regional agencies Show less